<DOC>
	<DOCNO>NCT02000414</DOCNO>
	<brief_summary>Peritoneal infection still frequent complication peritoneal dialysis patient . In France , It contribute technique failure , responsible 20 % case transfer hemodialysis . The risk direct mortality estimate 1 6 % accord study . Peritoneal infection involve dysfunction peritoneal membrane . Based recommendation International Society Peritoneal Dialysis , intraperitoneal route preferentially recommend . For many antibiotic , pharmacokinetics ( intravenous intraperitoneal ) study protocols IP administration validate . Daptomycin , cyclic lipopeptide natural , active Gram-positive bacteria . It present alternative vancomycin infection resistant pathogen . The stability daptomycin peritoneal dialysis fluid ( PDF ) test , antimicrobial activity well . Seven patient treated daptomycin intraperitoneally successfully . But study report pharmacokinetics daptomycin via IP route . We propose pharmacokinetic study daptomycin administer intraperitoneally 12 patient CAPD Gram-positive peritoneal infection .</brief_summary>
	<brief_title>Pharmacokinetics Study Intraperitoneal Administration Daptomycin Peritoneal Infection</brief_title>
	<detailed_description>Methodology : Prospective , open-label , non-randomized pharmacokinetic study . Daptomycin give IP CAPD fluid ( 200mg 2L Nutrineal ) daily , 6 hours-dwell time . The process dialysis do four time per day : three day ( 6,6 , 4 h ) one time night ( 8h ) . Duration treatment depend bacteria identify ( 14 21 day ) . Analyses perform data patient meet criterion inclusion exclusion . For patient , plasma , dialysate urine kinetics study . For parameter , mean standard deviation calculate . Number center &amp; patient : One center , twelve patient . Sample size justification : This observational pharmacokinetic study consecutive PD patient present Caen University Hospital peritoneal infection meet inclusion criterias one year . Population : CAPD patient Gram positive peritoneal infection</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Patients &gt; 18 year Hospitalized CAPD patient Gram positive peritoneal infection : ISPD criterias Presence two clinical sign symptom : abdominal pain , nausea , vomit , diarrhea , fever cloudy dialysate Peritoneal dialysate WBC &gt; 100/ÂµL least 50 % polymorphonuclear neutrophil cell Demonstration bacteria Gram stain culture peritoneal dialysis least 3 month write consent , obtain either patient , one his/her relatives , trust person designate beforehand , possible , emergency enrollment . patient life expectancy great 6 month Known allergy daptomycin Peritoneal infection Gram negative Patient CPK &gt; 5UNL patient already treat antibiotic , antifungal within 4 week prior event Patient hepatic impairment Patient argument extraperitoneal site infection Patient severe intercurrent illness ( eg , hematologic malignancy , patient chemotherapy ) Infection daptomycinresistant germ HMGCoA reductase , fibrates ciclosporin treatment Pregnant breastfeeding woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>intraperitoneal</keyword>
	<keyword>peritoneal dialysis</keyword>
	<keyword>daptomycin</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>peritonitis</keyword>
</DOC>